ClinicalTrials.gg
CompletedNCT07909187Updated Nov 2, 2026

Effects of Brainwave Audio on Sleep in People With Sleep Disturbances

An interventional study of Brainwave Audio in Sleep Disturbances, sponsored by Kaohsiung Armed Forces General Hospital. Completed at 1 site in Taiwan. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by Kaohsiung Armed Forces General Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Jul 2025, registered Oct 2026).
Updated Nov 2, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This exploratory study examines changes in sleep patterns during a four-week auditory stimulation intervention in 30 adults with self-reported sleep difficulties.

Participants use an 18-minute programmed audio recording daily before sleep for four weeks. The recording combines natural environmental sounds, rhythmic sound components, and background noise. Listening volume can be adjusted to a comfortable level.

Sleep assessments are conducted at the beginning of the study, Week 2, and Week 4. Each assessment lasts 24 minutes and includes 3 minutes of silence before the audio, 18 minutes of audio, and 3 minutes of silence afterward. Brain activity, eye movements, and chin muscle activity are recorded to classify wakefulness and non-rapid eye movement sleep stages.

This study evaluates whether brainwave audio intervention can improve sleep in people with sleep disturbances. Participants listen to the study audio, and their sleep is assessed before and after the intervention to examine changes in sleep patterns.

02

Conditions studied

  • Sleep Disturbances

Keywords

  • Auditory stimulation
  • Brainwave audio
  • Sleep stages
  • Sleep-state transitions
  • Electroencephalography
03

In context

Lead sponsor

Kaohsiung Armed Forces General Hospital is the lead sponsor of 4 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults.

Exclusion criteria

Exclusion Criteria:

  • Hearing impairment.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Brainwave Audio

    An 18-minute programmed audio recording combining natural environmental sounds, rhythmic sound components, and background noise. Participants listen daily before sleep for four weeks at a comfortable volume.

    Behavioral: Brainwave Audio

Interventions

  • BehavioralBrainwave Audio

    Participants listen to an 18-minute programmed audio recording daily before sleep for four weeks. The recording combines natural environmental sounds, rhythmic sound components, and background noise. All participants use the same audio program, with the listening volume adjusted to a comfortable level.

06

What researchers measure

Primary outcomes

  1. Epworth Sleepiness Scale (ESS)

    Daytime sleepiness is assessed using the Epworth Sleepiness Scale (ESS). Total scores range from 0 to 24, with higher scores indicating greater daytime sleepiness. Changes are calculated by comparing post-intervention scores with baseline scores.

    Time frame: All participants receive daily auditory stimulation for four weeks, with assessments at baseline, Week 2, and Week 4.

Secondary outcomes

  1. Electroencephalography (EEG)

    Electroencephalography (EEG) is used to assess changes in brain activity. Power in the delta, theta, alpha, and beta frequency bands is compared between baseline and the post-intervention assessment.

    Time frame: All participants receive daily auditory stimulation for four weeks, with assessments at baseline, Week 2, and Week 4.

07

Study locations

1 site
  • Kaohsiung Armed Forces General Hospital
    Kaohsiung City, 802301, Taiwan
08

References and documents

Individual participant data

Plan to share: Undecided — A decision on sharing individual participant data has not yet been made. Any future sharing will be subject to participant consent, privacy protection, and applicable ethical and institutional requirements.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07909187
Lead sponsor
Kaohsiung Armed Forces General Hospital
Responsible party
Sponsor
First posted
Nov 2, 2026
Start date
Jul 9, 2025
Primary completion
Oct 30, 2025
Completion
Nov 27, 2025
Last update
Nov 2, 2026

Study contacts

Yu-Tzu Chang, MD
principal investigator · Kaohsiung Armed Forces General Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion